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Gαi3-dependent inhibition of JNK
activity on intracellular membranes
Guillaume Bastin, Jin Ye Yang and Scott P. Heximer*
Department of Physiology, Heart and Stroke, Richard Lewar Centre of Excellence in Cardiovascular Research, University of
Toronto, Toronto, ON, Canada
Heterotrimeric G-protein signaling has been shown to modulate a wide variety of
intracellular signaling pathways, including the mitogen-activated protein kinase (MAPK)
family. The activity of one MAPK family class, c-Jun N-terminal kinases (JNKs), has
been traditionally linked to the activation of G-protein coupled receptors (GPCRs) at
the plasma membrane. Using a unique set of G-protein signaling tools developed
in our laboratory, we show that subcellular domain-specific JNK activity is inhibited
by the activation of Gαi3, the Gαi isoform found predominantly within intracellular
membranes, such as the endoplasmic reticulum (ER)–Golgi interface, and their associated
vesicle pools. Regulators of intracellular Gαi3, including activator of G-protein signaling
3 (AGS3) and the regulator of G-protein signaling protein 4 (RGS4), have a marked
impact on the regulation of JNK activity. Together, these data support the existence
of unique intracellular signaling complexes that control JNK activity deep within the
cell. This work highlights some of the cellular pathways that are regulated by these
intracellular complexes and identifies potential strategies for their regulation in mammalian
cells.
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Introduction
Heterotrimeric G-proteins function as molecular switches to regulate intracellular signaling path-
ways. The timing and duration of these signals are dependent on the lifetime of the activated
(GTP-bound) Gα subunit. The conventional model for receptor-mediated G-protein activation is
described herewith. In the basal state, a quiescent (GDP-bound) Gα subunit is complexed with
a Gβγ heterodimer and coupled to the intracellular surface of a GPCR. Receptor activation by
an extracellular stimulus results in the exchange of GTP for GDP on the Gα subunit and the
Abbreviations: AGS, activator of G-protein signaling; AP-1, activator protein 1; ATF2, activating transcription factor 2; BAD,
Bcl2-associated death promoter; Bcl2, B-cell lymphoma 2; BIM, Bcl2 interacting mediator of cell death; CFP, cyan fluorescent
protein; DHHC, Asp-His-His-Cys containing motif palmitoylating enzyme; DHHC, palmitoyl-CoA transferase active site
motif; EBSS, Earle’s balanced sodium solution; ER, endoplasmic reticulum; ERGIC, ER–Golgi intermediate compartment;
FOXO4, forkhead box protein O4; GAIP, G alpha interacting protein; GAP, GTPase-activating protein; GDI, guanosine
nucleotide dissociation inhibitor; GDP, guanosine-diphosphate; GEF, guanine nucleotide dissociation inhibitor; GFP, green
fluorescent protein; GPCR, G-protein coupled receptor; G-protein, guanine nucleotide binding protein; GTP, guanosine-
5,-triphosphate; HEK, human embryonic kidney; JNK, c-Jun N-terminal kinase; MAPK, mitogen-activated protein kinase;
MEKK, mitogen-activated protein/ERK kinase kinases; MKK, mitogen-activated protein kinase kinase; MKK4/7, mitogen-
activated protein kinase kinase 4/7; PI3K, phophoinositide 3-kinase; PM, plasma membrane; RFP, red fluorescent protein;
RGS, regulator of G-protein signaling; TGN, trans-Golgi network; WT, wild type; YFP, yellow fluorescent protein.
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dissociation of GTP-bound Gα from the Gβγ. This condition
marks the activated (“ON”) state of receptor signaling, during
which time the Gα and Gβγ subunits are free to engage down-
stream effector molecules, such as adenylyl cyclases, phospholi-
pases, and ion channels. Effector signaling is terminated following
Gα-catalyzed hydrolysis of GTP and reformation of the quiescent
(“OFF”) state of the GPCR complex. Based on their membrane-
spanning nature and their ability to transmit a wide array of
extracellular signals to appropriate intracellular effector pathways,
GPCRs represent one of the most important classes of therapeutic
targets for drug discovery (Hopkins and Groom, 2002).
A less-well characterized pathway for the activation of
G-protein α subunits involves regulatory proteins that reside
on intracellular membranes. Some Gα subunits, such as Gαi3,
for example, are localized primarily to intracellular membrane
pools like the trans-Golgi network (TGN) (De Vries et al., 1998),
LC3-positive autophagosomes (Garcia-Marcos et al., 2011), and
the ERGIC, a trafficking compartment between the ER and
the Cis-Golgi (Lo et al., 2015). A number of intracellular pro-
teins can regulate the activity of Gαi3 at sites distal to the
plasmamembrane receptor complexes discussed above. G-protein
dissociation inhibitors (GDIs) maintain the inactive signaling
conformation of the Gαi/o subunits by stabilizing the GDP-
bound state (Siderovski and Willard, 2005). One of the best
known GDIs is AGS3, a protein found primarily on intracel-
lular membranes at the Golgi, aggresomes, and LC3-positive
autophagosomes (Vural et al., 2010; Garcia-Marcos et al., 2011;
Oner et al., 2013). AGS3 can also prime Gαi/o subunits for
activation by non-receptor guanine nucleotide exchange factors
(GEFs), such as GIV (Lo et al., 2015). Importantly, GIV was
shown to activate Gαi3 as a consequence of growth factor stim-
ulation, supporting the premise that Gαi3 can be activated in
a receptor-independent manner. Notably, GIV was found to
be localized to the same compartments as Gαi3 including the
plasma membrane, ERGIC, TGN, and AGS3-labeled autophago-
somes (Garcia-Marcos et al., 2011; Lo et al., 2015). Another
family of Gα subunit regulators, the RGS protein superfamily,
functions as GTPase-activating proteins (GAPs) to inhibit G-
protein signaling (Berman et al., 1996). There are more than
35 proteins in the human genome. All RGS proteins are typi-
fied by their ~120 aa GAP domain that is capable of increas-
ing the rate of GTP hydrolysis by up to 2000-fold. They can
be further classified into subgroups based on the organization
of multiple modular protein–protein interaction domains that
direct their localization to specific signaling complexes within
the cell (Hollinger and Hepler, 2002). Like Gαi3, AGS3, and
GIV, some RGS proteins are concentrated within intracellular
membrane domains. Specifically, RGS19 is localized mainly to
the TGN and plasma membrane where it can regulate Gαi3-
mediated control of protein sorting and autophagic flux. We have
previously shown that RGS4, a member of the regulators of G-
protein signaling (RGS) protein superfamily, can traffic between
plasma membrane, endosomes, Golgi/TGN membrane compart-
ments within mammalian cells (Bastin et al., 2012). The ability
of RGS4 to target different intracellular subdomains was highly
dependent on the palmitoylation status of its amino-terminus.We
showed that differential palmitoylation Cysteine2 and Cysteine12
had markedly different effects on its localization and function.
Specifically, palmitoylation on Cys12 is critical for localization
to the plasma membrane and inhibition of receptor-mediated G-
protein signaling, whereas palmitoylation on Cys2 appears critical
for allowing RGS4 to traffic into the intracellular endosome/Golgi
pool. Together, these data suggested that RGS4 palmitoylation site
mutantsmight be useful genetic tools for understanding the extent
of plasma membrane versus intracellular G-protein activity that
contributes to complex signaling, such as that by members of the
MAPK family.
JNKs belong to the MAPK family. JNK isoforms have been
implicated in the pathophysiology of a range of diseases, including
Alzheimers disease (Akhter et al., 2015), arthritis (Schepetkin
et al., 2015), obesity (Nakamura et al., 2015), diabetes (Dong
et al., 2015), atherosclerosis (Kampschulte et al., 2014), abdom-
inal aortic aneurysm (Zhang et al., 2015), cardiac disease (Sun
et al., 2015), liver disease (Win et al., 2015), and tumorigen-
esis (Enomoto et al., 2015), making them an important target
for therapeutic intervention. JNKs form part of a wider protein
kinase cascade that mediates cellular responses to an array of
stress-related stimuli including: heat shock (Ruan et al., 2015),
hyperosmolarity (Gerke et al., 2014), ultraviolet irradiation (von
Koschembahr et al., 2015), cytokine activity (Choi et al., 2015),
and GPCRs (Yamauchi et al., 2000). Extracellular stress stim-
uli activate a cascade of kinases that involve mitogen-activated
protein/ERK kinase kinase (MEKKs), mitogen-activated protein
kinase kinase 4/7 (MKK4/7), and JNK1/2/3 assembled on intra-
cellular scaffold proteins, such as JNK-interacting protein (JIP)
(Whitmarsh, 2006). Once activated, JNKs can phosphorylate a
large number of cellular proteins that are connected to stress
signaling (Arthur and Ley, 2013). As their name suggests, JNKs
are thought to be one of the most important activators of the
transcription factor c-Jun via their ability to phosphorylate serines
63 and 73 within its transactivation domain (Li et al., 2004).
JNKs may also activate other transcription factors, such as: JunD
(Yazgan and Pfarr, 2002) and ATF2 (two members of the AP-1
transcription complex) (Gupta et al., 1995); hormone receptors
(Caelles et al., 1997); FOXO4 (Essers et al., 2004); and PPARγ1
(Yin et al., 2006). Of importance to this work, JNKs have also
been shown to phosphorylate a large number of protein sub-
strates outside of the nucleus suggesting that they have impor-
tant functions that are distinct from transcriptional regulation.
Specifically, JNKs have been shown to regulate the following
proteins in various compartments: cytoskeletal proteins – such
as the microtubule-associated protein, tau (Yoshida et al., 2004);
cytosolic proteins – including the E3 ligase, Itch (Gallagher et al.,
2006), insulin-receptor substrate-1 (Hilder et al., 2003) and vari-
ous 14-3-3 adaptors (Sunayama et al., 2005); mitochondrial pro-
teins – such as Bcl2 (Yamamoto et al., 1999), Bad (Yu et al., 2004),
and Bim (Lei and Davis, 2003); and plasma membrane-proximal
components of focal adhesions – such as paxillin (Huang et al.,
2003). It has been suggested that in order to phosphorylate such
a wide variety of intracellular substrates, JNKs must be localized
to the specific subcellular domains containing their substrates.
Indeed, distinct pools of activated JNKhave been identified in var-
ious intracellular compartments, including the nucleus (Kurinna
et al., 2004), endosome/lysosome (Parameswaran et al., 2013), and
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mitochondrial fractions (Almeida et al., 2000); however, little is
known about the neighborhood-specific molecules and pathways
that are involved in regulating these unique signaling domains.
We show here that the heterotrimeric G-protein, Gαi3, and the
intracellular proteins that regulate its activity, such as AGS3 and
RGS4, represent a novel signaling compartment that controls the
local activity levels of JNK. These data provide strong rationale
for characterization of the relative contribution of different intra-
cellular JNK pools to the overall JNK activity profile of a cell or
tissue, particularly when evaluating the significance of changing
phosho-JNK (p-JNK) levels on Western blots from whole cell
lysates.
Materials and Methods
Materials
The RGS4-YFP, RGS4-YFP (Cys2A and Cys12A), and RGS4-YFP
(EN-AA)mutants were described previously by our group (Bastin
et al., 2012; Bastin and Heximer, 2013). The EN-AA mutation in
the GAP domain of RGS4 (E87A, N88) renders the protein cat-
alytically inactive by preventing its interactionwithGαi (Srinivasa
et al., 1998). HEK293 cells (tsA-201 derivative) were a kind gift
from Zhong-Ping Feng (University of Toronto). All tissue culture
media and transfection reagents were purchased from Invitrogen
and Roche Scientific, respectively. Fluorescent-tagged versions
of the TGN marker protein TGN38 were from J. Lippincott-
Schwartz (National Institutes of Health, Bethesda, MD, USA).
Gαi3-CFP construct was created by insertion of CFP within an
intracellular loop of Gαi3 and was a kind gift from Catherine
Berlot (Weis Center for Research, Geisinger Clinic, Danville, PA,
USA). AGS3-GFPwas a kind gift from Stephen Lanier (University
of South Carolina). Antibodies against JNK and phospho-JNK
were purchased from Cell Signaling with the respective catalog
numbers: #9252S, #9251S. Horseradish peroxidase-coupled anti-
rabbit secondary antibodies were from Cell Signaling (CAT #
70745) respectively. Unless otherwise stated, all other reagents and
chemicals were from Sigma.
Cell Culture
HEK293 or MEF cells were grown in Dulbecco’s modified Eagle’s
medium (DMEM):Ham’s F12 medium (1:1) (Gibco, respectively
CAT # 11995-065 and # 11765-054), supplemented with 10% (v/v)
heat-inactivated fetal bovine serum (Gibco, CAT # 12483020),
2mM glutamine (Life Technology, CAT # 25030081), 10μg/ml
streptomycin, and 100 units/ml penicillin (Life Technology, CAT
# 15140122) at 37°C in a humidified atmosphere with 5% CO2.
To reduce the impact of growth factors and hormones on global
cell signaling, cells were maintained in serum-free Earle’s Bal-
anced SodiumSolution (EBSS, Life Technology, CAT #14155-063)
supplemented with 200mg/L of both CaCl2 and MgCl2.
Molecular Biology
For subcellular localization studies, RGS4-YFP and cysteine point
mutations expression plasmids were generated in the pEYFP-
C1 as described previously (Bastin et al., 2012). Constitutively
active Gαi3-R178C-CFPwas created by site-directedmutagenesis
methods using the forward strand primers 50-cca act cag cca
gat gtt ctt cgg aca tgt-30 together with its reverse complement.
The R178C mutation has been previously shown to impair the
GTP hydrolysis activity by the α subunit, rendering the protein
locked in its activated state. RGS proteins are however, capable
of increasing the GTPase rate of these mutants. All plasmid con-
structs were purified using the Endofree Maxi kit (Qiagen, CAT #
12362) and verified by sequencing of the complete protein-coding
region.
Confocal Microscopy
HEK293 cells were plated at 50% confluence in tissue culture-
treated microscopy dishes (Ibidi, CAT # 81156) and transfected
overnight with 1μg of each construct to be tested using 2.5μL
of Xtremegene HP transfection reagent according to the manu-
facturer’s instructions (Roche, CAT # 06366236001). After 24 h,
dishes were examined by confocal microscopy to determine their
localization containing transfected cells. Spinning disk confocal
microscopy was performed on live cells at 37°C in an envi-
ronmental chamber maintained at 5% CO2 using a WaveFX
Spinning-Disk Confocal Microscope (Quorum Technologies,
Guelph, Canada), comprised of an Olympus IX81 microscope
stand, a Yokogawa CSU10 spinning-disk unit, and a Hamamatsu
C9100-13 EM-CCD camera, controlled by Volocity software.
Imaging was performed using a 60/1.42N.A. oil immersion
objective, using 405, 488, and 561 nm solid-state lasers for the
excitation of CFP, YFP, and mRFP respectively. Z-stack intervals
were 0.3–0.35μm. Emission wavelength parameters of each were
matched to the appropriate bandpass emission filters, and where
more than one fluorescent channel was examined in a single cell,
the possibility of bleed through fluorescence was excluded prior to
evaluation of the co-localization of different proteins. All confocal
images were collected and analyzed with the Volocity software
package and figures were subsequently generated using Microsoft
Office.
Western Blotting
Proteins were transferred to (Trans-Blot, BioRad) nitrocellulose
membrane. Membranes were blocked for 1 h with Tris-buffered
saline 0.1% Tween-20 (TBST) with 5% bovine serum albumin.
Primary antibodies were diluted in TBST containing 5% BSA
as per the vendor’s instructions and incubated with membranes
overnight at 4°C before removing by washing. Horseradish perox-
idase linked-secondary antibodies were diluted (1:3000) in TBST
with 5% BSA was added for 2 h, before washing and signal detec-
tion using Super Signal West Pico Chemi-luminescent Substrate
(Thermo Scientific).Western blots were analyzed by densitometry
using Image J software analysis.
Data Collection, Management, and Statistical
Analysis
At the outset of each series of microscopy experiments, the exper-
imenter was blinded to the identity of the transfectants until data
collection and analysis were completed. Where indicated, one-
way and two-way ANOVA with Tukey’s post hoc analysis were
used to analyze the experimental results. *p< 0.05 was considered
significant. Error bars depict standard error of themean (SEM) for
all graphs.
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Results and Discussion
Our previous work with the RGS4 protein showed that there
exists at least two distinct membrane-bound pools of RGS4within
mammalian cells (Bastin et al., 2012). These pools consisted of
the known pool at the plasma membrane and a newly appreci-
ated pool that targeted intracellular membranes, such as endo-
somes, Golgi, and other punctate structures (Bastin and Heximer,
2013). The demonstration that differential palmitoylation of cys-
teine residues in the amino-terminus of RGS4 could alter its
distribution between these two membrane pools guided efforts
to demonstrate potential functional differences between RGS4
at these different locations in the cell. While it was relatively
straightforward to show that prevention of RGS4 trafficking to
the plasma membrane via mutation of Cys12, the palmitoyla-
tion site adjacent to its membrane-targeting amphipathic helix,
could inhibit the ability of RGS4 to inhibit Gq-mediated sig-
naling from the plasma membrane, it was more complicated to
demonstrate a functional consequence of the Cys2 mutation that
prevented RGS4 localization to the intracellular membrane pool.
Our attention turned to regulation of intracellular Gαi3 after
we discovered overlapping expression of RGS4-YFP-containing
punctae with those targeted by CFP-tagged Gαi3 (Figure 1).
Notably, the extent of co-localization on intracellular punctae
was typically greater (larger number of punctae/cell) between
RGS4 and the constitutively active Gαi3 (R178C; RC) com-
pared to Gαi3 (WT). A significant plasma membrane signal
FIGURE 1 | RGS4 Shows preferential co-localization with Gα i3RC.
HEK293 cells were co-transfected with RGS4-YFP (yellow), and either Gαi3
(WT)- or Gαi3 (RC)-CFP (blue) to assess the extent of co-localization using
spinning disk confocal microscopy. The merged view is a composite
two-channel view of cells expressing the two indicated constructs. Data are
representative of at least 100 dual-transfected cells. Arrows indicate
co-localization on intracellular endosomal structures between RGS4 and
Gαi3. Scale bars represent 1μm.
was also present for Gαi3, suggesting that like RGS4, Gαi3 may
also traffic between the plasma membrane and the intracellular
membrane compartments. These data suggested that intracellu-
lar RGS4 and Gαi3 may target some of the same intracellular
domains to co-ordinately regulate specific intracellular signaling
pathways. Consistent with previous reports, Gαi3 and AGS3 were
also found together on intracellular membrane structures in our
expression system (Figure 2). Notably, in the presence of AGS3,
we observed dramatically reduced co-localization of RGS4 and
WT Gαi3 compared to Gαi3 (RC) (marked by arrowheads in
Figures 3A,B). Together, these data suggested that Gαi3 may
shuttle between AGS3-containing (GDP-boundGαi3) and RGS4-
containing (GTP-bound Gαi3) compartments depending on its
state of activation. These data simply reflect the preferences of the
RGS box for GTP-bound Gαi3 and AGS3 GPR/GoLoco motifs
for inactive/GDP-bound Gαi3; however, preliminary evidence
to argue against this notion comes from experiments showing
the catalytically dead RGS4 (EN-AA) mutant had similar co-
localization with Gαi3 (RC)-containing punctae as wild-type
RGS4. Moreover, the co-expression of Gαi3 with either RGS4 or
AGS3 did not alter their localization in any discernable manner.
These data suggest that these proteins traffic together on sim-
ilar endosome-like structures where they may be co-localized,
without necessarily interacting stably with one another. Such a
system would allow RGS4 to fine tune the levels of Gαi3 activ-
ity, while they are in the same compartment and then pass off
inactiveGαi3-GDP to anothermembrane compartment (presum-
ably an AGS3-containing one), where Gαi3 could be primed for
reactivation.
We next examined JNK activity, an intracellular signaling path-
way that we expected to be sensitive to changes in Gαi3 activity.
Indeed, the prediction, based on previous reports where JNK was
activated downstream of various GPCRs, was that increased Gαi3
FIGURE 2 | Co-localization of Gα i3 with AGS3 in mammalian cells. HEK
293 cells were co-transfected AGS3-GFP (green) and Gαi3WT-CFP (blue) to
assess the extent of co-localization using spinning disk confocal microscopy.
The merged view is a composite two-channel view of cells expressing the two
indicated constructs. Data are representative of at least 100 dual-transfected
cells. Arrows indicate co-localization between AGS3 and Gαi3 on intracellular
endosomal structures. Scale bars represent 1μm.
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FIGURE 3 | Co-localization of Gα i3 with AGS3 and RGS4 is dependent
on its activation state. HEK 293 cells were co-transfected with RGS4-RFP
(red), AGS3-GFP (green), and either Gαi3WT-CFP (A) or Gαi3RC-CFP (B) (blue)
to assess the extent of co-localization using spinning disk confocal microscopy.
The merged view is a composite three-channel view of cells expressing all three
constructs. Shown below are the indicated single channel views or
double-channel combinations. Data are representative of at least 100
triple-transfected cells. Arrows indicate co-localization between RGS4 and
Gαi3, whereas arrowheads indicate co-localization between AGS3 and Gαi3.
Scale bars represent 1μm.
FIGURE 4 | Activated Gα i3 reduces the levels of phospho(p)-JNK in
HEK 293 cells. Relative changes in endogenous p-JNK/total JNK ratio were
quantified in the presence of Gαi3-CFP (WT) and (RC) by Western Blotting.
The left panel show a representative Western blot of p-JNK/total JNK
regulation by Gαi3 (WT) and (RC) expression. The right panel shows the
quantification of p-JNK/total JNK ratio in four independent experiments
(one-way ANOVA with Tukey post hoc test *P<0.01).
activity would increase the level of intracellular JNK activation
as determined by Western blotting for phosphorylated JNK (p-
JNK). Surprisingly, however, the relative activity level of Gαi3
in our system inversely correlated with the observed p-JNK lev-
els. Specifically, Gαi3 (RC) mediated a profound reduction of
p-JNK in our system compared to Gαi3 (WT) (Figure 4). As
expected, both Gαi3 clones showed a reduced level of p-JNK
relative to empty vector controls (data not shown). Together, these
data suggested the novel premise that Gαi3 signaling inhibits
intracellular JNK activation. Since, AGS3 functions as a GDI on
intracellular membrane pools, we next examined whether AGS3-
mediated stabilization of GDP-bound (inactive) Gαi3 may also
regulate JNK activation. Consistent with our new model, AGS3
expression markedly increased the levels of p-JNK observed in
our cells relative to YFP control (Figure 5). These data suggest
that there exists a tonic level of endogenous Gαi-mediated JNK
inhibition in HEK293 cells that can be modulated by the expres-
sion of AGS3 or other similar GDI partners. In support of this, we
also found that pertussis toxin increased p-JNK levels in a dose-
dependent fashion (data not shown). Finally, we examined the
effect of another potent Gαi3 inhibitor, RGS4, on the regulation
of JNK activity in our system (Figure 5). Endogeneous Gαi3 with
wild-type RGS4 expression resulted in a modest decrease of p-
JNK compared to expression of its catalytically inactive EN-AA
mutant. At first glance, these data seemed inconsistent with the
observations for AGS3 and Gαi3 above. However, a more com-
pelling story emerged when we examined the effects of the RGS4
palmitoylation site mutants Cys2A and Cys12A on intracellular
JNK signaling. Notably, for the Cys2 mutant, when RGS4 was
nearly exclusively localized to the plasma membrane (i.e., unable
to target the intracellular membrane pool), there was a marked
decrease in p-JNK levels. By contrast, for the Cys12A mutant
when RGS4 was nearly exclusively localized to intracellular mem-
branes, there was a marked increase in p-JNK levels to those even
exceeding the levels observed for the catalytically inactive (EN-
AA) RGS4 construct. Taken together, these data suggest that total
JNK signaling in a cell or tissue represents a combination of JNK
pools that likely includes cytosolic, nuclear, plasma membrane,
and intracellular fractions. Wild-type RGS4, by virtue of its ability
to target and inhibit multiple intracellular signaling pools showed
a much different effect on JNK signaling compared to either of
the two individual palmitoylation site mutants. It should be noted,
however, that we cannot rule out the possibility that mutation
of Cys2 and its effects on RGS4 stability, via preventing N-end
rule degradation of the protein may also have contributed to its
ability to regulate intracellular JNK activity. A mechanistic model
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FIGURE 5 | Expression of AGS3 and intracellular RGS4 increased
phospho(p)-JNK in HEK 293 cells. (A) Relative changes in endogenous
p-JNK/total JNK ratio were quantified in the presence of AGS3 or empty vector
as indicated. The left panel shows a representative Western blot of p-JNK/total
JNK regulation by AGS3 expression. The right panel shows the quantification of
p-JNK/total JNK ratio in four independent experiments. (B) The effect of RGS
activity of RGS4 on p-JNK/total JNK was observed by Western blot with the
catalytic dead mutant RGS4 (ENAA). The effect of palmitoylation site of RGS4
on the variation of p-JNK/total JNK was observed by Western blot with the
expression of Cys2 and Cys12 mutants. The left panel shows a representative
Western blot of p-JNK/total JNK regulation by the indicated constructs. The
right panel shows the quantification of p-JNK/total JNK ratio in four independent
experiments [one-way ANOVA with post hoc Tukey *P<0.005 for (A), and
*P<0.05 for (B)].
showing the spatial distribution of JNK, Gαi3, and its regulators
is presented in Figure 6.
It is important to note that the mechanism by which Gαi3
inhibits intracellular JNK remains to be identified. It will be
critical to determine whether this unique effect is mediated by
direct protein–protein interaction between Gαi3 and JNK, or
alternatively whether other effector pathways downstream of acti-
vated Gαi3, such as adenylyl cyclases or PI3Ks, may be involved.
Although the effects of Gαi3 (RC) are consistent with an effect
mediated by the α subunit, further studies will be required to
determine whether βγ or other βγ-like partners may also par-
ticipate in the complexes that regulate intracellular JNK activity.
Moreover, while it appears likely that the effects of AGS3 and
pertussis toxin are exerted via their activity on Gαi3, we can-
not rule out the possibility that other endogenous Gαi subunits
may also contribute to intracellular JNK regulation. These new
findings may also be useful in the design of strategies to iden-
tify and selectively target specific intracellular JNK pools and
their associated physiologic activities. At this stage, it remains
to be determined whether the JNK pool regulated by Gαi3 in
our system is associated with one of the known regulatory func-
tions of JNK, such as apoptosis, cell migration, transcription,
autophagy, and ER–Golgi trafficking, or whether it has a yet
undiscovered function. It seems likely, however, based on the
known localization and intracellular function of Gαi3 that this
pool of JNK will be somehow linked to intracellular membrane
trafficking at the level of the ER–Golgi and their associated vesic-
ular compartments.
It may be important to determine whether this signaling
domain contains one or more of the different known JNK
isoforms. Mammalian JNKs are encoded by three distinct genes
(Jnk1, Jnk2, and Jnk3). Alternative splicing generates up to 10
different protein products varying in size from 46 to 55 kDa, all of
which have been sequenced and analyzed for possible specificity
determinants. Despite their the high level of homology (>80%),
differences between amino- and carboxy-terminal sequence or
exon usage suggest the existence of functional specificity (Gupta
et al., 1996; Guo and Whitmarsh, 2008). While isoform-specific
knockouts and the development of pan-specific JNK inhibitors
have thus far been very useful in the study of JNK function
(Gehringer et al., 2015), the simple fact remains that for most JNK
substrates, there is still very little information regarding isoform-
specific affinity. As suggested by our data above, targeting discreet
intracellular protein complexes, such as endosomal Gαi3, or its
regulators and effectors, may offer unique molecular strategies for
modulating JNK activity. One such strategy might be to alter the
plasma membrane versus endosomal distribution profile of the
Gαi3 regulator RGS4. This might be accomplished by promot-
ing site-selective palmitoylation of its amino-terminus. Currently,
studies are underway to evaluate the specificity of the various
palmitoyl-CoA transferases (DHHC family proteins) for Cys2 and
Cys12 with this in mind. It is also interesting that the amino-
terminal domain ofGαi3 itself requires palmitoylation for its opti-
mal membrane targeting and function. Thus, regulation of Gαi3
by specific DHHC isoforms might provide another useful access
point for regulating the intracellular JNK pool. Lastly, modulation
of AGS3 activity may provide another unique opportunity to
modulate intracellular JNK via Gαi3. Using structural techniques
and data, other groups have identified the residues within AGS3
that allow its binding (Peterson et al., 2002; Willard et al., 2008)
and GDI activity (Kimple et al., 2002, 2004) for Gαi. Intriguingly,
these data may ultimately inform the design of peptide mimetics
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FIGURE 6 |Model for intracellular functions of p-JNK and the effect of
heterotrimeric G-proteins on p-JNK accordingly to the cellular
compartment. P-JNK has been correlated to distinct functions accordingly to
its intracellular compartments. Indeed, p-JNK regulates gene transcription upon
nuclear localization, apoptosis when it targets mitochondria. P-JNK also
regulates signals located at the ER–Golgi vicinity to enhance autophagy and at
the plasma membrane to regulate cell migration. Heterotrimeric G-protein
coupled receptor activation at the plasma membrane is known to increase levels
of p-JNK in mammalian cells. Here, we showed that activated Gαi3 protein
significantly inhibits p-JNK and inhibitors of Gαi/o proteins, AGS3 and RGS4,
promote p-JNK when located on intracellular compartments. Conversely, RGS4
located selectively at the plasma membrane potently inhibited p-JNK.
that selectively could interfere with AGS3–Gαi3 interactions to
regulate Gαi3 activity and local JNK regulation.
In summary, we have uncovered a new role for Gαi3-mediated
function in mammalian cells – specifically as an inhibitor of JNK
activation and signaling. The model for the proposed mecha-
nism is shown in Figure 6. Activation of Gαi3 (in this case via
receptor-independent GEF activity) on intracellular membrane
pools leads to inhibition of local JNK activation. Then, illustrated,
the regulation Gαi3 activity (cycling between different nucleotide
states) may be coordinated by other intracellular players, includ-
ing AGS3, RGS proteins, and GIV/girdin (GEF). Changes in
intracellular JNK activity may then alter physiologic activities at
one or more of the other intracellular locations where unique
JNK pools are thought to be important, such as mitochondria
(apoptosis), ER–Golgi interface (autophagy), or the nucleus (tran-
scriptional programs). This work supports further characteriza-
tion of the novel protein complexes regulated by heterotrimeric
G-proteins that are found localized to intracellular membrane
pools deep within the cell, distal to the influences of most surface
GPCRs. The characterization of receptor-independent G-protein
activation and signaling, and its relationship to cellular health
and homeostasis is an important emerging area of investigation
that is likely to reveal a number of new cellular functions for
Gα subunits, as well as their intracellular binding partners and
effectors.
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